Fasken acted on behalf of Filament Health Corporation in connection with its going public transaction. Filament Health Corp. (NEO: FH), a natural psychedelic drug discovery and extraction...
You must be a Standard 1 Year member to access this content.
Fasken advised Wildpack Beverage (formerly Wild Leaf Ventures Group Inc.) in its going public transaction, which constituted a “qualifying transaction” within the meaning of the TSX...
You must be a Standard 1 Year member to access this content.
Fasken advised Wildpack Beverage (formerly Wild Leaf Ventures Group Inc.) in its going public transaction, which constituted a “qualifying transaction” within the meaning of the TSX...
You must be a Standard 1 Year member to access this content.
Fasken acted for the underwriters. On March 31, 2021, Leucrotta Exploration Inc. closed its previously announced bought-deal financing of 41,096,000 units of the Company at a price of C$0.73...
You must be a Standard 1 Year member to access this content.
